Showing 36,902 results

Bad science & bogus treatments

I Watched Charlie Sheen on The Dr. Oz Show So You Don't Have To

Editor's pick
Poz
14 January 2016
New & experimental HIV treatments

ABIVAX announces positive top-line clinical Phase IIa data for novel HIV drug-candidate ABX464

Editor's pick
Medical News Today
13 January 2016
The search for a cure

New amfAR/UCSF Institute Aims to Advance Basic Science of HIV Cure Research

Editor's pick
HIVandhepatitis.com
13 January 2016
TB treatment

Unlikely perk of prison life: Free, speedy TB treatment

Editor's pick
Mail & Guardian
12 January 2016
Tuberculosis & HIV

Protesters demand BRICS triple TB research funding

Editor's pick
Health-e
12 January 2016

Quest for tuberculosis vaccine begins as scientists aim to beat disease by 2035

Editor's pick
The Guardian
12 January 2016
Drug-resistant TB

Did poor bedside manner cause the rise of multidrug-resistant TB?

Editor's pick
Devex
12 January 2016
Tuberculosis & HIV

TB community borrowing a page from HIV/AIDS

Editor's pick
Science
12 January 2016
Young people

Legal barriers to adolescent participation in HIV and STI research need to be removed

Editor's pick
Rice University press release
12 January 2016
New & experimental hepatitis C treatment

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

Editor's pick
AbbVie press release
11 January 2016
PrEP

Kenya: Approval of Truvada a game changer in anti-HIV/Aids effort

Editor's pick
The East African
11 January 2016
Young people

Senior MPs pile pressure on Nicky Morgan as PSHE deadline missed

Editor's pick
Politics Home
11 January 2016
Vaginal rings & topical PrEP

Microbicide Development Hinges on New Products Administered in New Ways

Editor's pick
IAVI Report
11 January 2016
Drug-resistant TB

TAG’s Response to the U.S. Action Plan for Combating Multidrug Resistant Tuberculosis

Editor's pick
Treatment Action Group
11 January 2016
HIV prevention policy

Anthony Fauci: No more excuses. We have the tools to end the HIV/AIDS pandemic.

Editor's pick
Washington Post
11 January 2016
Harm reduction

US: It Took 20 Years For The Government To Pay For An Obvious Way To Prevent HIV

Editor's pick
FiveThirtyEight
11 January 2016
New & experimental hepatitis C treatment

Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India

Editor's pick
Mylan press release
8 January 2016
New & experimental HIV treatments

Janssen, ViiV Healthcare Formalize Injectable Rilpivirine + Cabotegravir Phase 3 as HIV Treatment

Editor's pick
Street Insider
8 January 2016
Improving HIV care

San Francisco's Strut health and wellness center opens

Editor's pick
Bay Area Reporter
7 January 2016
PrEP

DIY healthcare: importing PrEP into the UK

Editor's pick
Prepster
7 January 2016
Harm reduction

After Decades, Congress Effectively Lifts Ban On Federally Funded Needle Exchanges

Editor's pick
BuzzFeed
6 January 2016
Activism & civil society

16 HIV Advocates to Watch in 2016

Editor's pick
My Fabulous Disease
6 January 2016
UK health services

Terrence Higgins Trust announces new CEO

Editor's pick
Terrence Higgins Trust
6 January 2016
HIV prevention policy

The State of the HIV Epidemic

Editor's pick
Poz
6 January 2016